Table 2 Distribution of macular edema subtype and outer retinal layer status according to the anatomical site of inflammation and their relationship with central foveal thickness and best-corrected visual acuity
Type of uevitis | CME (N = 74) | DME (N = 59) | SRF (N = 12) | Status of EPIS | Status of IZ | ||
|---|---|---|---|---|---|---|---|
Integrity (N = 86) | Disruption (N = 59) | Integrity (N = 87) | Disruption (N = 58) | ||||
Anterior | 28 (37.84%) | 23 (38.98%) | 0 (0.0%) | 28 (32.56%) | 23 (38.98%) | 27 (31.03%) | 24 (41.38%) |
Intermediate | 22 (29.73%) | 19 (32.20%) | 0 (0.0%) | 20 (23.26%) | 21 (35.59%) | 20 (22.99%) | 21 (36.20%) |
Posterior | 15 (20.27%) | 7 (11.86%) | 3 (25.0%) | 21 (24.42%) | 4 (6.78%) | 21 (24.14%) | 4 (6.90%) |
Panuveitis | 9 (12.16%) | 10 (16.96%) | 9 (75.0%) | 17 (19.76%) | 11 (18.64%) | 19 (21.84%) | 9 (15.52%) |
Mean CFT (mm) | 460.3 ± 143.9 | 296.7 ± 61.4 | 505.8 ± 201.9 | 349.7 ± 125.3 | 467.2 ± 155.1a | 352.5 ± 127.7 | 465 ± 155.0a |
Mean BCVA (Snellen eq.) | 0.63 ± 0.41 (20/80) | 0.24 ± 0.33 (20/30) | 0.52 ± 0.39 (20/60) | 0.24 ± 0.26 (20/30) | 0.77 ± 0.40a (20/125) | 0.26 ± 0.28a (20/30) | 0.76 ± 0.41a (20/125) |